Skip to main content

FDA recall, , Moderate risk

GenTeal Tears and Systane Lubricant Eye Gel

Systane Lubricant Eye Gel Night Gel may lack assurance of sterility.

What happened

Alcon Research LLC of Fort Worth, Texas, recalled GenTeal Tears Lubricant Eye Gel and Systane Lubricant Eye Gel Night Gel due to a lack of assurance of sterility, based on FDA inspection observations that may impact product quality. The recall began on April 21, 2026, and was added to the FDA's Enforcement Report on April 24, 2026. The products were distributed nationwide within the United States.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

2 products

Match the lot code and NDC listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz)

    NDC
    • 0065-8064-01
    Lot code
    • 9T20
    • 9T50
    • 9T59
    • 1U30
    • 1U48
    • 4V15
    • 7V61
    • 1W47
    • 1W49
    • 1X14
  2. Systane, Lubricant Eye Gel, Night Gel, Sterile, 10g (0.35 oz), Processed in France for: Alcon Laboratiroes, Inc., Fort Worth, TX 76134, USA

    NDC
    • 0065-0474-01
    Lot code
    • 9T21
    • 1U63
    • 2U47
    • 6V00
    • 6V12
    • 8V54
    • 9V55
    • 8V58
    • 9V39
    • 9V97
    • 1W39
    • 1W40
    • 1X76

Recall details

Company began the recall
Sold in

Nationwide within the United States

Company
Alcon Research LLCFort Worth, Texas
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98815
Recall numbers
D-0491-2026 to D-0492-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)